Research Portal

Dr Andrew Pierce

Lecturer (Teaching & Research)

Affiliations

ORCID: 0000-0001-5995-2469

Contact info

Location: Brambell, Room 412

Email: a.pierce@bangor.ac.uk

Current Position: Lecturer, Medical and Health Sciences

Other external Positions: Honorary Lecturer, Division of Cancer Sciences, The University of Manchester

11 - 20 out of 63Page size: 10
Sort by: Type
  1. Article › Research › Peer-reviewed

  2. BCR-ABL alters the proliferation and differentiation response of multipotent hematopoietic cells to stem cell factor.

    Pierce, A., E, S., S, A. & AD, W., 2002, In: Oncogene. 21, p. 3068-3075

    Research output: Contribution to journal › Article › peer-review

  3. BCR/ABL modulates protein phosphorylation associated with the etoposide-induced DNA damage response.

    F, G., AJ, W., S, T., DN, P., E, S., A, P. & AD, W., 12 Jun 2012, In: Journal of Proteomics. 77, p. 14-26

    Research output: Contribution to journal › Article › peer-review

  4. Bcr-Abl protein tyrosine kinase activity induces a loss of p53 protein that mediates a delay in myeloid differentiation.

    Pierce, A., E, S., S, W., C, D., JM, F., J, M., PJ, O-L., TM, D. & AD, W., 16 Nov 2000, In: Oncogene. 19, p. 5487-5497

    Research output: Contribution to journal › Article › peer-review

  5. Bcr-Abl-mediated molecular mechanism for apoptotic suppression in multipotent haemopoietic cells: a role for PKCbetaII.

    D, X., Pierce, A., N, U-D., AD, W. & PJ, O-L., Feb 2004, In: Cellular Signalling. 16, 2, p. 145-156

    Research output: Contribution to journal › Article › peer-review

  6. Changes in the proteome associated with the action of Bcr-Abl tyrosine kinase are not related to transcriptional regulation.

    DL, S., CA, E., A, P., SJ, G. & AD, W., 1 Nov 2002, In: Molecular and Cellular Proteomics. 1, 11, p. 876-884

    Research output: Contribution to journal › Article › peer-review

  7. Chronic myeloid leukemia CD34+ cells have elevated levels of phosphatidylinositol 3,4,5 trisphosphate (PtdIns(3,4,5)P3) and lack a PtdIns(3,4,5)P3 response to cytokines and chemotactic factors; effects reversed by imatinib.

    HG, H., Pierce, A., WA, S., C, P. D., A, G., A, I., E, S. & AD, W., 18 Aug 2005, In: Leukemia. p. 1851-1853

    Research output: Contribution to journal › Article › peer-review

  8. Published

    Combination of curaxin and tyrosine kinase inhibitors display enhanced killing of primitive Chronic Myeloid Leukaemia cells

    Pearson, S., D. Whitton, A. & Pierce, A., 31 Mar 2022, In: PLoS ONE. 17, 3, 11 p., e0266298.

    Research output: Contribution to journal › Article › peer-review

  9. Comparative proteomics of primitive hematopoietic cell populations reveals differences in expression of proteins regulating motility.

    CA, E., R, T., D, B., A, P., J, S., Y, L., HG, H., A, G., CP, D., SJ, G., E, S. & AD, W., 15 May 2004, In: Blood. p. 3751-3759

    Research output: Contribution to journal › Article › peer-review

  10. Comprehensive library generation for identification and quantification of endometrial cancer protein biomarkers in cervico-vaginal fluid

    Njoku, K., Chiasserini, D., Geary, B., Pierce, A., Jones, E. R., Whetton, A. & Crosbie, E., 23 Jul 2021, In: Cancers.

    Research output: Contribution to journal › Article › peer-review

  11. Correction: Identification of nuclear protein targets for six leukemogenic tyrosine kinases governed by post-translational regulation (PLoS ONE)

    Pierce, A., Williamson, A., Jaworska, E., Griffiths, J. R., Taylor, S., Walker, M., Aspinall O'Dea, M., Spooncer, E., Unwin, R. D., Poolman, T., Ray, D. & Whetton, A. D., 2012, In: PLoS ONE. 8, 6

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 3 4 5 6 7 Next